| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥913.5B | ¥924.2B | -1.2% |
| Operating Income | ¥105.9B | ¥88.2B | +20.1% |
| Ordinary Income | ¥117.0B | ¥98.3B | +19.0% |
| Net Income | ¥92.4B | ¥69.2B | +33.5% |
| ROE | 8.5% | 7.0% | - |
FY2025 full-year results showed revenue of 913.5B yen (YoY -1.2%), operating income of 105.9B yen (+20.1%), ordinary income of 117.0B yen (+19.0%), and net income of 92.4B yen (+33.5%). Despite a marginal decline in top-line revenue, the company achieved strong double-digit profit growth across all profit metrics. Operating margin expanded to 11.6% from 9.5% in the prior year, driven by effective cost management with SG&A expenses maintained at 5.2% of revenue. The significant improvement in net income of 23.2B yen was supported by enhanced profitability at the operating level, stable non-operating income contributions of 11.4B yen primarily from dividend and interest income, and extraordinary gains of 16.7B yen. EPS increased 35.7% to 313.99 yen, reflecting the strong earnings performance. Operating cash flow reached 159.1B yen (+14.9%), representing 1.90x net income and confirming robust cash generation capability. The company maintained an exceptionally strong balance sheet with equity ratio of 85.2% and minimal interest-bearing debt of 8.8B yen.
Revenue declined 1.2% to 913.5B yen, falling 10.7B yen short of the prior year. The Gas segment recorded revenue of 680.5B yen, down 4.5B yen YoY, while the Iodine segment achieved 152.0B yen, up 15.7B yen YoY. The Other segment contributed 85.7B yen, up 18.2B yen. Within segment analysis, the Gas segment accounts for 74.5% of total revenue and serves as the core business, though it experienced demand headwinds. Conversely, the Iodine segment demonstrated resilience with growth momentum driven by favorable market conditions for iodine products and brine. Cost of sales decreased to 695.7B yen from 706.7B yen, resulting in gross profit of 217.8B yen with an improved gross margin of 23.8% versus 23.6% YoY. This 0.2 percentage point margin expansion reflects better product mix and operational efficiency despite lower volumes.
On the profit side, SG&A expenses declined to 47.2B yen from 48.9B yen, representing a reduction of 1.7B yen. The SG&A-to-revenue ratio improved to 5.2% from 5.3%, demonstrating disciplined overhead management. These factors combined to deliver operating income of 105.9B yen, up 17.7B yen or 20.1%. Non-operating income totaled 11.4B yen, consisting primarily of interest income of 4.7B yen and dividend income of 5.1B yen, with minimal non-operating expenses of 0.4B yen. This resulted in ordinary income of 117.0B yen, up 18.7B yen.
Extraordinary items included 16.7B yen in gains and 2.4B yen in losses, with the losses comprising 2.3B yen in disposal losses and 0.3B yen in impairment charges. The net extraordinary gain of 14.3B yen represented a non-recurring benefit that amplified the year's bottom-line performance. Income tax expense was 38.9B yen on profit before tax of 131.3B yen, yielding an effective tax rate of 29.6%. After deducting non-controlling interests of 8.6B yen, net income attributable to owners reached 83.8B yen. The difference between ordinary income of 117.0B yen and net income of 92.4B yen (including NCI) is explained by the extraordinary items gain of 14.3B yen and tax expense of 38.9B yen, which together account for the 24.6B yen gap.
This represents a revenue down, profit up pattern, where operational efficiency and cost discipline more than compensated for the top-line shortfall, supplemented by significant non-recurring gains.
The Gas segment generated revenue of 680.5B yen (down 4.5B yen YoY) and operating income of 49.7B yen (down 1.2B yen YoY), resulting in an operating margin of 7.3%. As the largest segment contributing 74.5% of total revenue, Gas represents the company's core business, though it faced volume headwinds during the period. The Iodine segment delivered revenue of 152.0B yen (up 15.7B yen) and operating income of 87.7B yen (up 12.1B yen), achieving a substantially higher operating margin of 57.7%. The Iodine segment's profitability is markedly superior to Gas, reflecting the high-value nature of iodine and iodine compound products. Despite representing only 16.6% of revenue, Iodine contributed 63.8% of total segment operating profit, underscoring its role as a critical profit driver. The margin differential of 50.4 percentage points between the two segments highlights the company's portfolio composition, with a high-volume, lower-margin Gas business complemented by a specialized, high-margin Iodine business. Segment profit before corporate allocation increased 7.7B yen to 137.3B yen, with the Iodine segment accounting for the majority of this growth.
[Profitability] ROE of 8.5% reflects moderate return on equity, supported by net profit margin of 10.1% and operating margin of 11.6%, which improved from 9.5% in the prior year. The 2.1 percentage point expansion in operating margin demonstrates enhanced operational efficiency and cost management effectiveness. Gross profit margin was 23.8%, up 0.2 points YoY, while the SG&A ratio declined to 5.2% from 5.3%. [Financial Health] The company maintains an exceptionally strong balance sheet with equity ratio of 85.2% compared to 83.2% previously, indicating low financial leverage. Interest-bearing debt totaled just 8.8B yen against total assets of 1,277.7B yen. Current ratio stands at 430.4%, reflecting substantial liquidity cushion. The debt-to-equity ratio of 0.08x and debt-to-EBITDA of 0.05x both underscore minimal leverage. [Cash Quality] Cash and deposits reached 305.5B yen, supplemented by short-term investment securities of 83.5B yen, providing combined liquid assets of 389.0B yen against short-term debt of just 3.3B yen, yielding cash coverage of 117.9x. Working capital expanded to 407.5B yen from 357.8B yen, supporting operational flexibility. [Investment Efficiency] Total asset turnover of 0.72x reflects the capital-intensive nature of the business. Investment securities increased significantly to 200.4B yen from 158.4B yen, representing a 42.0B yen or 26.6% increase that suggests active deployment of surplus cash into long-term investments or strategic holdings.
Operating cash flow of 159.1B yen represents 1.72x net income of 92.4B yen, confirming strong cash-backed earnings quality. Operating CF before working capital changes totaled 170.9B yen, indicating robust core cash generation. Working capital movements included inventory increase of 0.7B yen, receivables decrease contributing 3.4B yen, and payables decrease consuming 14.9B yen, resulting in net working capital outflow of 12.2B yen. Income taxes paid of 31.6B yen aligned with the tax expense, while interest and dividends received of 9.6B yen bolstered operating cash inflows. Investing cash flow was negative 132.6B yen, primarily driven by capital expenditures of 82.0B yen for property, plant and equipment, along with other investment activities. The CapEx-to-depreciation ratio of 1.30x indicates continued investment in productive capacity above the maintenance level. Free cash flow of 26.5B yen (operating CF plus investing CF) remained positive despite substantial investment outlays, demonstrating the company's ability to fund growth while generating surplus cash. Financing cash flow of negative 16.2B yen reflected dividend payments and other capital allocation activities. The company's cash position remains exceptionally robust, providing ample dry powder for future investments, shareholder returns, or strategic opportunities.
Ordinary income of 117.0B yen compared to operating income of 105.9B yen indicates a net non-operating contribution of 11.1B yen, comprising interest income of 4.7B yen and dividend income of 5.1B yen as primary components, offset by minimal interest expense of 0.1B yen. Non-operating income represented 1.2% of revenue, reflecting a modest but stable contribution from the company's financial assets and investments. The increase in investment securities to 200.4B yen from 158.4B yen suggests a strategic emphasis on generating passive income through equity investments and fixed-income holdings. Extraordinary gains of 16.7B yen less extraordinary losses of 2.4B yen resulted in a net extraordinary gain of 14.3B yen, which represented a significant non-recurring boost to net income. These gains are not expected to recur at similar levels, requiring adjustment for sustainable earnings assessment. Operating cash flow of 159.1B yen exceeded net income of 92.4B yen by 72%, indicating healthy earnings quality with profits converting efficiently to cash. The accrual ratio of negative 5.9% further confirms that earnings are not inflated by aggressive accrual accounting, and the negative ratio suggests conservative recognition practices. Overall, the company's earnings quality is strong on an operating basis, though the impact of extraordinary items should be isolated when evaluating normalized profitability.
Full-year forecast calls for revenue of 870.0B yen (YoY -4.8%), operating income of 92.0B yen (-13.2%), ordinary income of 103.0B yen (-12.0%), and net income of 69.4B yen. Actual results exceeded guidance across all metrics, with revenue achieving 105.0% of forecast (913.5B yen vs 870.0B yen), operating income reaching 115.1% (105.9B yen vs 92.0B yen), ordinary income attaining 113.6% (117.0B yen vs 103.0B yen), and net income delivering 133.1% of target (92.4B yen vs 69.4B yen). The substantial outperformance relative to initial guidance, particularly at the net income level with 33.1 percentage points above forecast, reflects better-than-expected operational execution, cost control, and the benefit of extraordinary gains not fully anticipated in the original guidance. Management has revised the year-end dividend forecast from 26.00 yen to 30.00 yen per share, adding 4.00 yen to the prior estimate, which demonstrates confidence in the full-year earnings realization and commitment to enhanced shareholder returns following the strong performance. The dividend revision announcement was issued on February 13, 2026, concurrent with the earnings release.
The company declared an annual dividend of 42.00 yen per share for FY2025, comprising interim dividend of 20.00 yen and year-end dividend of 22.00 yen, though the forecast year-end dividend has been revised upward to 30.00 yen as noted in the guidance update. Based on the initially declared dividends totaling 42.00 yen against EPS of 313.99 yen, the payout ratio is 13.4%. However, incorporating the revised year-end dividend of 30.00 yen would result in a total dividend of 50.00 yen (20.00 yen interim plus 30.00 yen year-end) and a payout ratio of 15.9%. The reported XBRL payout ratio of 18.2% likely reflects the revised dividend figure. Free cash flow of 26.5B yen provides coverage of 2.23x against dividend payments, indicating ample cash generation to support distributions. No share buyback programs were disclosed in the available data. The total return ratio, considering dividends alone without buybacks, aligns with the payout ratio of approximately 18.2%. The company's conservative payout ratio combined with strong cash flow generation and minimal debt provides substantial capacity for future dividend growth or incremental shareholder returns through buybacks if management chooses to deploy additional capital to shareholders.
Demand volatility in core Gas segment: The Gas segment, representing 74.5% of revenue, experienced a YoY revenue decline of 4.5B yen, indicating sensitivity to industrial demand cycles and macroeconomic conditions. Prolonged weakness in gas consumption due to economic slowdown or structural shifts in energy markets could constrain top-line growth and pressure operating leverage.
Commodity price exposure in Iodine business: While the Iodine segment delivered strong results with 57.7% operating margin, iodine and iodine compound prices are subject to global supply-demand dynamics and price volatility. A reversal in favorable market conditions could materially impact the profitability of this high-margin segment, which contributed 63.8% of segment operating profit.
Investment securities valuation risk: Investment securities increased 26.6% to 200.4B yen, representing 15.7% of total assets. This concentrated exposure to equity and fixed-income holdings subjects the company to market risk, with potential valuation losses impacting comprehensive income and equity. The unrealized gains on securities of 13.8B yen recorded in comprehensive income demonstrate the materiality of mark-to-market movements.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of 11.6% reflects solid profitability for an integrated gas and specialty chemicals company, with particularly strong contribution from the high-margin Iodine segment at 57.7%. The company's net profit margin of 10.1% demonstrates effective conversion of revenues to bottom-line earnings, supported by low leverage and favorable non-operating income. Compared to typical industrial gas and specialty chemical companies, the margin profile appears competitive, though the segment mix creates variability.
Financial Health: Equity ratio of 85.2% positions the company in the top tier of financial strength among industrial peers. Minimal interest-bearing debt of 8.8B yen and a debt-to-equity ratio of 0.08x indicate virtually no financial leverage, providing maximum financial flexibility. This conservative capital structure exceeds typical industry medians for chemical and gas distribution companies, many of which operate with moderate leverage.
Efficiency: Asset turnover of 0.72x reflects the capital-intensive nature of gas infrastructure and iodine production facilities. While this is moderate for the sector, the company's focus appears to be on margin optimization rather than asset velocity. The ROE of 8.5% is reasonable given the minimal leverage, though asset-light competitors may achieve higher returns.
(Industry: Integrated Gas & Specialty Chemicals, Comparison: Historical company trends, Source: Proprietary analysis)
Strong profitability improvement despite revenue decline: The company achieved operating income growth of 20.1% and net income growth of 33.5% while revenue declined 1.2%, demonstrating operating leverage and effective cost management. The expansion of operating margin by 2.1 percentage points to 11.6% reflects structural efficiency gains that may be sustainable. This margin improvement trajectory, if maintained, could support earnings growth even in flat revenue environments.
Exceptional financial fortress with excess cash deployment: The company maintains 389.0B yen in combined cash and short-term investments against minimal debt of 8.8B yen, creating substantial financial flexibility. The 26.6% increase in investment securities to 200.4B yen signals active deployment of surplus capital into long-term investments, potentially for passive income generation or strategic positioning. This capital allocation strategy suggests management's view that internal growth opportunities are limited, warranting external investment or preparation for inorganic growth through M&A.
Segment mix drives earnings resilience: The high-margin Iodine segment (57.7% operating margin) contributed 63.8% of segment operating profit despite representing only 16.6% of revenue, providing a profitability buffer against weakness in the core Gas business. The Iodine segment's growth of 12.1B yen in operating income more than offset the Gas segment's decline of 1.2B yen, demonstrating portfolio diversification benefits. Continued strength in iodine markets and any expansion of this high-value segment would disproportionately benefit consolidated profitability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.